Lonza Group Ag (OTCMKTS:LZAGY – Get Free Report) reached a new 52-week high during trading on Thursday. The company traded as high as $77.39 and last traded at $77.39, with a volume of 305 shares. The stock had previously closed at $76.89.
Lonza Group Price Performance
The stock has a 50-day simple moving average of $70.54 and a two-hundred day simple moving average of $67.13. The company has a current ratio of 1.66, a quick ratio of 1.21 and a debt-to-equity ratio of 0.42.
Lonza Group Company Profile
Lonza Group AG is a Swiss contract development and manufacturing organization (CDMO) that supports pharmaceutical and biotechnology companies throughout the life cycle of their products. The company provides research, process development, testing, manufacturing, and regulatory support for therapies and other healthcare products, helping customers advance programs from early development through commercial production.
Lonza’s activities include the development and manufacture of biologics, small-molecule medicines, and cell and gene therapies.
Featured Stories
- Five stocks we like better than Lonza Group
- Visa’s Toll Booth Keeps Collecting, But the Price Is Rising
- Alphabet’s Cloud Is Paying Off—But the Bill for Building It Keeps Growing
- Why Meta Platform’s $100 Billion Financing Plan Is A Boon for Chip Giant Broadcom
- Enphase Energy’s Solar Slump Raises a Question About Its AI Data Center Ambitions
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.
